Skip to main content

Table 4 In-dwell characteristics and adverse events of PORT-inserted patients, stratified by solid tumours versus haematological malignancies

From: Impact of the COVID-19 pandemic on subcutaneous venous port-related complications in patients with cancer: a retrospective case–control study

  Haematological malignancy Solid tumours HR 95% CI p-value
n = 56 n = 201
Total catheter days 8226 29,071
CD per patient, median (IQR) 181 (63) 175 (69) 0.496
Mortality, n (%) 7 (12.5) 36 (17.9) 0.7 0.3–1.6 0.416
Days to death median (IQR) 100 (111) 67 (76) 0.1
DVT, n (%) 4 (7.1) 2 (1.0) 7.3 1.3–40.1 0.021
DVT/1000 CD 0.49 0.07
Days to DVT median (IQR) 15(36) 85 (−)
All catheter infections, n (%) 4 (7.1) 9 (4.5) 1.6 0.5–5.3 0.42
Infection/1000 CD 0.49 0.31
Local infection, n (%) 3 (5.4) 9 (4.5) 1.2 0.3–4.5 0.766
CRI, n (%) 3 (5.4) 3 (1.5) 0.12
CRBSI, n (%) 3 (5.4) 2 (1.0) 5.5 0.9–33.1 0.061
CRBSI/1000 CD 0.36 0.07
Days to infection median (IQR) 23 (37) 56 (85) 0.643
Haematoma, n (%) 3 (5.4) 10 (5.0) 1.0
Antibiotics, n (%) 26 (46.4) 22 (10.1) < 0.001
Mechanical, n (%) 3 (5.4) 6 (3.0) 1.8 0.5–7.3 0.398
Mechanical/1000 CD 0.36 0.21
Days to mechanical event, median (IQR) 4 (−) 16 (57) 0.604
Occlusion, n (%) 8 (14.3) 18 (9.0) 1.6 0.7–3.7 0.256
Occlusion/1000 CD 0.97 0.62
Days to occlusion, median (IQR) 39 (144) 17 (43) 0.317
All grade adverse events, n (%) 21 (37.5) 37 (18.4) 1.8 1–3.2 0.053
All grade adverse events/1000 CD 2.55 1.27
Days to all grade adverse events, median (IQR) 26 (82) 22 (63) 0.64
  1. HR hazard ratio, CI confidence interval, CD catheter days, IQR interquartile range, DVT deep venous thrombosis, CRI catheter-related infection, CRBSI catheter-related bloodstream infection